2-hydroxyphytanic acid has been researched along with nad in 1 studies
| Studies (2-hydroxyphytanic acid) | Trials (2-hydroxyphytanic acid) | Recent Studies (post-2010) (2-hydroxyphytanic acid) | Studies (nad) | Trials (nad) | Recent Studies (post-2010) (nad) |
|---|---|---|---|---|---|
| 8 | 0 | 1 | 30,121 | 88 | 5,663 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jakobs, C; Jansen, GA; Schor, DS; Verhoeven, NM; Wanders, RJ | 1 |
1 other study(ies) available for 2-hydroxyphytanic acid and nad
| Article | Year |
|---|---|
Phytanic acid alpha-oxidation: decarboxylation of 2-hydroxyphytanoyl-CoA to pristanic acid in human liver.
Topics: Biomarkers; Cell Fractionation; Coenzyme A; Decarboxylation; Fatty Acids; Humans; Liver; Microbodies; Microsomes; NAD; Phytanic Acid; Zellweger Syndrome | 1997 |